IT Tech Packaging, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results

    0
    145

    BAODING, China, March 28, 2024 /PRNewswire/ — IT Tech Packaging, Inc. (NYSE American: ITP) ("IT Tech Packaging" or the "Company"), a leading manufacturer and distributor of diversified paper products in North China, today announced its unaudited financial results for the fourth quarter and audited financial results for the fiscal year ended December 31, 2023.

    Mr. Zhenyong Liu, Chairman and Chief Executive Officer of the Company, commented, " In 2023, the company achieved a revenue of $86.55 million and a gross profit of $1.00 million. The overall performance improved due to slightly increased sales volume. Considering current conditions, including supportive policies and the implementation of plastic-restriction-orders,  we expect a rise in domestic demand for packaging paper. In the long run, we will focus on acquiring new customers, reducing costs and improving efficiency and ensuring safe and environmentally friendly production. Moreover, we plan to implement flexible pricing and inventory management in line with market trends to maintain cash flow and minimize risks while achieving reasonable profit levels."

    Fourth Quarter 2023 Financial Results

    For the Three Months Ended December 31,

     ($ millions)

    2023

    2022

     % Change

     Revenues

    20.96

    21.37

    -1.91 %

     Regular Corrugating Medium Paper ("CMP")*

    17.02

    17.28

    -1.52 %

     Light-Weight CMP**

    3.45

    3.77

    -8.54 %

     Offset Printing Paper

    -0.01

    n/a

     Tissue Paper Products

    0.47

    0.25

    87.04 %

      Face Masks

    0.01

    0.06

    -80.65 %

     Gross profit

    0.25

    1.03

    -75.61 %

     Gross profit (loss) margin

    1.19 %

    4.80 %

    3.61pp****

     Regular Corrugating Medium Paper ("CMP")*

    5.32 %

    8.28 %

    2.96 pp****

     Light-Weight CMP**

    5.50 %

    10.28 %

    4.78 pp****

     Offset Printing Paper

    41.02 %

    n/a

     Tissue Paper Products***

    -182.10 %

    -315.16 %

    133.06 pp****

     Face Masks

    -21.19 %

    27.47 %

    -48.66 pp****

     Operating income (loss)

    -3.80

    -0.49

    -673.41 %

     Net income (loss)

    -3.98

    -11.91

    -66.54 %

     EBITDA

    0.11

    3.77

    -97.08 %

     Basic and Diluted earnings (loss) per share

    -0.40

    -1.19

    66.39 %

     * Products from PM6

     ** Products from PM1

     *** Products from PM8 and PM9

     **** pp represents percentage points

    • Revenue decreased by 1.91% to approximately $20.96 million, primarily attributable to a decrease in the average selling price("ASP") of CMP, partially offset by an increase in sales volume of regular CMP, light-weight CMP and offset printing paper.
    • Gross profit decreased by 75.61% to approximately $0.25 million. Total gross margin decreased by 3.61 percentage point to 1.19%.  
    • Loss from operations was approximately $3.80 million, compared to $0.49 million for the same period of previous year.
    • Net loss was approximately $3.98 million, or loss of $0.40 per basic and diluted share, compared to $11.91 million, or loss of $1.19 per basic and diluted share, for the same period of previous year.
    • Earnings before interest, taxes, depreciation and amortization ("EBITDA") decreased by 97.08% to approximately $0.11 million.

    Revenue

    For the fourth quarter of 2023, total revenue decreased by approximately $0.41 million, or 1.91%, to approximately $20.96 million from approximately $21.37 million for the same period of previous year. The decrease in total revenue was mainly due to the decrease in ASP of CMP and offset printing paper, partially offset by increase in sales volume of regular CMP, light-weight CMP and offset printing paper.

    The following table summarizes revenue, volume and ASP by product for the fourth quarter of 2023 and 2022, respectively:

     For the Quarter Ended December 31,

    2022

    2023

     Revenue
    ($’000)

     Volume
    (tonne)

     ASP ($/tonne)

     Revenue
    ($’000)

     Volume
    (tonne)

     ASP
    ($/tonne)

     Regular CMP

    17,281

    41,941

    412

    17,019

    46,958

    362

     Light-Weight CMP

    3,768

    9,365

    402

    3,446

    9,847

    350

     Offset Printing Paper

    -9

     Tissue Paper Products

    253

    234

    1,083

    474

    480

    987

     Total

    21,302

    51,540

    413

    20,929

    57,285

    365

     Revenue
    ($’000)

     Volume
    (thousand
    pieces)

     ASP
    ($/thousand
    pieces)

     Revenue
    ($’000)

     Volume
    ($/thousand
    pieces)

     ASP
    ($/thousand
    pieces)

     Face Masks

    57

    1,330

    43

    10

    360

    31

    Revenue from CMP, including both regular CMP and light-Weight CMP, decreased by $0.58 million, or 2.78%, to approximately $20.46 million and accounted for 97.62 % of total revenue for the fourth quarter of 2023, compared to approximately $21.05 million, or 98.49% of total revenue, for the same period of previous year. The Company sold 56,805 tonnes of CMP at an ASP of $360/tonne in the fourth quarter of 2023, compared to 51,306 tonnes at an ASP of $410/tonne in the same period of previous year.

    Of the total CMP sales, revenue from regular CMP decreased by approximately $0.26 million, or 1.52%, to approximately $17.02 million, resulting from sales of 46,958 tonnes at an ASP of $362/tonne, during the fourth quarter of 2023, compared to revenue of approximately$17.28  million, resulting from sales of 41,941 tonnes at an ASP of $412/tonne, for the same period of previous year. Revenue from light-weight CMP decreased by approximately $0.32 million, or 8.54%, to approximately $3.45 million, resulting from sales of 9,847 tonnes at an ASP of $350/tonne for the fourth quarter of 2023, compared to revenue of approximately $3.77 million, resulting from sales of 9,365 tonnes at an ASP of $402/tonne for the same period of previous year.

    Revenue from offset printing paper was $nil for the three months ended December 31, 2023 and 2022, respectively.

    Revenue from tissue paper products increased by $0.22 million, or 87.04%, to approximately $0.47 million, resulting from sales of 480 tonnes at an ASP of $987/tonne, for the fourth quarter of 2023, compared to revenue of approximately$0.25million, resulting from sales of 234 tonnes at an ASP of $1,083/tonne for the same period of previous year.

    Revenue from face masks decreased by $45,791, or 80.65%, to approximately $10,983  for the fourth quarter ended December 31, 2023, from $56,774 for the same period of 2022. The Company sold 360 thousand pieces of face masks for the fourth quarter ended December 31, 2023, compared to 1,330 thousand pieces of face masks for the same period of 2022.

    Gross Profit and Gross Margin

    Total cost of sales increased by $0.37 million, or 1.81%, to approximately $20.71 million for the fourth quarter of 2023 from approximately $20.34 million for the same period of previous year. For paper products, overall cost of sales per tonne was $361 for the fourth quarter of 2023, compared to $394 for the same period of previous year. Costs of sales per tonne for regular CMP, light-weight CMP, offset printing paper, and tissue paper products were $343, $331, $nil and $2,785, respectively, for the fourth quarter of 2023, compared to  $378, $361, $nil and $4,494, respectively, for the same period of previous year.

    Total gross profit was approximately $0.25 million for the fourth quarter of 2023, compare to the gross profit of approximately $1.03 million for the same period of previous year as a result of factors described above. Overall gross margin was 1.19% for the fourth quarter of 2023, compared to 4.8% for the same period of previous year. Gross profit (loss) margins for regular CMP, light-weight CMP, offset printing paper, tissue paper products and face mask products were 5.32%, 5.50%, 41.02%, -182.10% and -21.19%, respectively, for the fourth quarter of 2023, compared to 8.28%, 10.28%, n/a, -315.16% and 27.47%, respectively, for the same period of previous year.

    Selling, General and Administrative Expenses

    Selling, general and administrative expenses ("SG&A") increased by $1.86 million, or 122.80%, to approximately $3.38 million for the fourth quarter of 2023 from approximately $1.52 million for the same period of previous year.

    Income (Loss) from Operations

    Loss from operations was approximately $3.80 million for the fourth quarter of 2023, an increase of $3.31 million, or 673.41%, from $0.49 million for the same period of previous year. Operating loss margin was 18.13% for the fourth quarter of 2023, 2.30% for the same period of previous year.

    Net Income (Loss)

    Net loss was approximately $3.98 million, or $0.40 loss per basic and diluted share for the fourth quarter of 2023, representing a decrease of $7.92 million, or 66.54%, from  $11.91 million, or $1.19 loss per basic and diluted share, for the same period of previous year.

    EBITDA

    EBITDA was approximately $0.11 million for the fourth quarter of 2023, compared to approximately $3.77 million for the same period of previous year.

    Note 1: Non-GAAP Financial Measures

    In addition to our U.S. GAAP results, this press release includes a discussion of EBITDA, a non-GAAP financial measure as defined by the Securities and Exchange Commission ("SEC"). The Company defines EBITDA as net income before interest, income taxes, depreciation and amortization. EBITDA is a key measure used by management to evaluate our results and make strategic decisions. Management believes this measure is useful to investors because it is an indicator of operational performance. Because not all companies use identical calculations, the Company’s presentation of EBITDA may not be comparable to similarly titled measures of other companies, and should not be viewed as an alternative to measures of financial performance or changes in cash flows calculated in accordance with the U.S. GAAP.

    Reconciliation of Net Income to EBITDA

    (Amounts expressed in US$)

     For the Three Months Ended December 31,

     ($ millions)

    2023

    2022

     Net income (loss)

    -3.98

    -11.91

     Add: Income tax

    -0.00

    11.87

             Net interest expense

    0.22

    0.24

             Depreciation and amortization

    3.65

    3.57

     EBITDA

    0.11

    3.77

     

    Full Year Ended December 31, 2023 Financial Results

     For the Year Ended December 31,

     ($ millions)

    2023

    2022

     % Change

     Revenues

    86.55

    100.35

    -13.76 %

     Regular Corrugating Medium Paper ("CMP")*

    67.37

    82.30

    -18.14 %

     Light-Weight CMP**

    14.52

    16.43

    -11.61 %

     Offset Printing Paper

    3.22

    0

    n/a

     Tissue Paper Products

    1.31

    1.36

    -3.76 %

      Face Masks

    0.11

    0.26

    -58.86 %

     Gross profit

    1.00

    4.75

    -78.97 %

     Gross profit (loss) margin

    1.16 %

    4.74 %

    3.58 pp****

     Regular Corrugating Medium Paper ("CMP")*

    5.27 %

    7.39 %

    -2.12 pp****

     Light-Weight CMP**

    2.59 %

    9.42 %

    -6.83 pp****

     Offset Printing Paper

    2.41 %

    n/a

     Tissue Paper Products***

    -230.86 %

    -216.34 %

    14.52 pp****

     Face Masks

    -10.49 %

    26.11 %

    -36.60 pp****

     Operating income (loss)

    -9.58

    -5.30

    -80.52 %

     Net income(loss)

    -9.95

    -16.57

    -39.98 %

     EBITDA

    5.61

    10.96

    -48.81 %

     Basic and Diluted earnings (loss) per share

    -0.99

    -1.66

    40.36 %

     * Products from PM6

     ** Products from PM1

     *** Products from PM8 and PM9

     **** pp represents percentage points

    Revenue

    For the year ended December 31, 2023, total revenue decreased by $13.81 million, or 13.76%, to approximately $86.55 million from approximately $100.35 million for 2022. The decrease in total revenue was mainly due to the decrease in average selling price ("ASP") of CMP, partially offset by increase in sales volume of regular CMP, light-weight CMP and offset printing paper .

    The following table summarizes revenue, volume and ASP by product for the years ended December 31, 2023 and 2022, respectively:

     For the Year Ended December 31,

    2022

    2023

     Revenue
    ($’000)

     Volume
    (tonne)

     ASP ($/tonne)

     Revenue
    ($’000)

     Volume
    (tonne)

     ASP ($/tonne)

     Regular CMP

    82,297

    180,977

    455

    67,371

    182,870

    368

     Light-Weight CMP

    16,428

    37,354

    440

    14,520

    40,953

    355

     Offset Printing Paper

    3,215

    5,573

    577

     Tissue Paper Products

    1,356

    1,273

    1,065

    1,305

    1,205

    1,083

     Total

    100,082

    219,604

    456

    86,412

    230,601

    375

     Revenue
    ($’000)

     Volume
    (thousand
    pieces)

     ASP
    ($/thousand
    pieces)

     Revenue
    ($’000)

     Volume
    ($/thousand
    pieces)

     ASP
    ($/thousand
    pieces)

     Face Masks

    258

    5,625

    46

    106

    3,383

    31

    Revenue from CMP, including both regular CMP and light-Weight CMP decreased by $16.83 million, or 17.05%, to approximately $81.89 million, and accounted for 94.62% of total revenue for the year ended December 31, 2023, compared to  approximately $98.73 million, or 98.38% of total revenue for 2022. The Company sold 223,823 tonnes of CMP at an ASP of $366/tonne in the year ended December 31, 2023, compared to 218,331 tonnes at an ASP of $452/tonne in 2022.

    Of the total CMP sales, revenue from regular CMP decreased by $14.93 million, or 18.14%, to approximately $67.37 million, resulting from sales of 182,870 tonnes at an ASP of $368/tonne during the year ended December 31, 2023, compared to revenue of approximately $82.30 million, resulting from sales of 180,977 tonnes at an ASP of $455/tonne for 2022. Revenue from light-weight CMP decreased by $1.91 million, or 11.61%, to approximately$14.52 million, resulting from sales of 40,953 tonnes at an ASP of $355/tonne for the year ended December 31, 2023, compared to revenue of approximately $16.43 million, resulting from sales of 37,354 tonnes at an ASP of $440/tonne for 2022.

    Revenue from offset printing paper was $3.22 for the year ended December 31, 2023. Due to COVID-19, our paper production was restricted and production of offset printing paper was suspended in 2022.

    Revenue from tissue paper products decreased by $0.05 million, or 3.76%, to approximately $1.31 million, resulting from sales of 1,205 tonnes at an ASP of $1,083/tonne, for the year ended December 31, 2023, compared to revenue of approximately $1.36 million, resulting from sales of 1,273 tonnes at an ASP of $1,065/tonne for 2022.

    Revenue from face masks decreased by $0.15 million, or 58.86%, to approximately $0.11 million for the year ended December 31, 2023, from approximately $0.26 million for 2022. The Company sold 3,383 thousand pieces of face masks for the year ended December 31, 2023, compared to 5,625 thousand pieces of face masks for 2022.

    Gross Profit and Gross Margin

    Total cost of sales decreased by $10.05 million, or 10.51%, to approximately $85.55 million for the year ended December 31, 2023 from approximately $95.60 million for 2022. The decrease in overall cost of sales was mainly due to due to the decrease of material costs of CMP in the year ended December 31, 2023.  Costs of sales per tonne for regular CMP, light-weight CMP, offset printing paper, tissue paper products were, $349, $345, $563, and $3,584, respectively, for the year ended December 31, 2023 compared to $421, $398, $nil, and $3,370 respectively, for 2022.

    Total gross profit decreased by $3.75 million, or 78.97%, to approximately $1.00 million for the year ended December 31, 2023 from approximately $4.75 million for 2022. Overall gross margin decreased by 3.58 percentage points to 1.16% for the year ended December 31, 2023 from 4.74% for 2022. Gross margins for regular CMP, light-weight CMP, offset printing paper, tissue paper products and face mask products were 5.27%, 2.59%, 2.41, -230.86% and -10.49%, respectively, for the year ended December 31, 2023, compared to 7.39%, 9.42%, nil, -216.34% and 26.11%, respectively, for 2022.

    Selling, General and Administrative Expenses

    SG&A expenses decreased by $0.98 million, or 9.78%, to approximately $9.08 million for the year ended December 31, 2023 from approximately $10.06 million for 2022. As a percentage of total revenue, SG&A expenses was 10.45% for the year ended December 31, 2023, compared to 10.02% for 2022.

    Income (Loss) from Operations

    Loss from operations decreased by $4.27million, or 80.52% to approximately $9.58 million for the year ended December 31, 2023 from $5.30 million for 2022. Operating loss margin was 11.06% for the year ended December 31, 2023, compared to 5.29% for 2022.

    Net Income (Loss)

    Net loss increased by $6.63 million, or 39.98%, to approximately $9.95  million, or loss per basic and diluted share of $0.99, for the year ended December 31, 2023, compared to net loss of approximately $16.57 million, or  loss  per basic and diluted share of $1.66 for 2022.

    EBITDA

    EBITDA decreased by $5.35 million, or 48.81%, to approximately $5.61 million for the year ended December 31, 2023 from approximately $10.96 million for 2022.

    Note 1: Non-GAAP Financial Measures

    In addition to our U.S. GAAP results, this press release includes a discussion of EBITDA, a non-GAAP financial measure as defined by the Securities and Exchange Commission ("SEC"). The Company defines EBITDA as net income before interest, income taxes, depreciation and amortization. EBITDA is a key measure used by management to evaluate our results and make strategic decisions. Management believes this measure is useful to investors because it is an indicator of operational performance. Because not all companies use identical calculations, the Company’s presentation of EBITDA may not be comparable to similarly titled measures of other companies, and should not be viewed as an alternative to measures of financial performance or changes in cash flows calculated in accordance with the U.S. GAAP.

    Reconciliation of Net Income to EBITDA
    (Amounts expressed in US$)

     For the Year Ended December 31,

     ($ millions)

    2023

    2022

     Net income (loss)

    -9.95

    -16.57

     Add: Income tax

    0.35

    11.71

             Net interest expense

    0.98

    1.03

             Depreciation and amortization

    14.23

    14.79

     EBITDA

    5.61

    10.96

    Cash, Liquidity and Financial Position

    As of December 31, 2023, the Company had cash and bank balances, short-term debt (including bank loans, current portion of long-term loans from credit union and related party loans), and long-term debt (including loan from credit union) of approximately $3.92 million, $8.03 million and $4.50 million, respectively, compared to  approximately $9.52 million, $11.16 million and $4.20 million, respectively, at the end of 2022.

    Net accounts receivable was approximately $0.58 million as of December 31, 2023, compared to  approximately $nil million as of December 31, 2022. Net inventory was approximately $3.56 million as of December 31, 2023, compared to approximately $2.87 million at the end of 2022. As of December 31, 2023, the Company had current assets of approximately $28.36  million and current liabilities of approximately $21.42 million, resulting in a working capital of approximately $6.94 million. This was compared to current assets of approximately $47.17 million and current liabilities of approximately $17.64 million, resulting in a working capital of approximately $29.53 million at the end of 2022.

    Net Cash provided by operating activities was approximately $12.87 million for the year ended December 31, 2023, compared to approximately $10.72 million for 2022. Net cash used in investing activities was approximately $22.24 million for the year ended December 31, 2023, compared to approximately $10.90 million for 2022. Net cash provided by financing activities was approximately $4.41 million for the year ended December 31, 2023, compared to net cash used in financing activities of approximately $0.88 million for 2022.

    About IT Tech Packaging, Inc.

    Founded in 1996, IT Tech Packaging, Inc. is a leading manufacturer and distributor of diversified paper products and single-use face masks in North China. Using recycled paper as its primary raw material (with the exception of its tissue paper products), ITP produces and distributes three categories of paper products: corrugating medium paper, offset printing paper and tissue paper products. With production based in Baoding and Xingtai in North China’s Hebei Province, ITP is located strategically close to the Beijing and Tianjin region, home to a growing base of industrial and manufacturing activities and one of the largest markets for paper products consumption in the country. ITP has been listed on the NYSE American since December 2009. For more information, please visit: https://www.itpackaging.cn/.

    Safe Harbor Statements

    This press release may contain forward-looking statements. These forward-looking statements involve inherent risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, including risks outlined in the Company’s public filings with the Securities and Exchange Commission, including the Company’s latest annual report on Form 10-K. All information provided in this press release speaks as of the date hereof. Except as otherwise required by law, the Company undertakes no obligation to update or revise its forward-looking statements.

    For more information, please contact:

    At the Company
    Email: ir@itpackaging.cn
    Tel: +86 0312 8698215

     

     

     

    IT TECH PACKAGING, INC.

    CONSOLIDATED BALANCE SHEETS

    AS OF DECEMBER 31, 2023 AND 2022

    December 31,

    December 31,

    2023

    2022

    ASSETS

    Current Assets

    Cash and bank balances

    $

    3,918,938

    $

    9,524,868

    Restricted cash

    472,983

    Accounts receivable (net of allowance for doubtful accounts of $11,745 and
    $881,878 as of December 31, 2023 and December 31, 2022, respectively)

    575,526

    Inventories

    3,555,235

    2,872,622

    Prepayments and other current assets

    18,981,290

    27,207,127

    Due from related parties

    853,929

    7,561,858

    Total current assets

    28,357,901

    47,166,475

    Prepayment on property, plant and equipment

    1,031,502

    Operating lease right-of-use assets, net

    528,648

    672,722

    Finance lease right-of-use assets, net

    1,939,970

    Property, plant, and equipment, net

    163,974,022

    151,569,898

    Value-added tax recoverable

    1,883,078

    2,066,666

    Deferred tax asset non-current

    Total Assets

    $

    194,743,649

    $

    204,447,233

    LIABILITIES AND STOCKHOLDERS’ EQUITY

    Current Liabilities

    Short-term bank loans

    $

    423,567

    $

    5,598,311

    Current portion of long-term loans

    6,874,497

    4,835,884

    Lease liability

    100,484

    224,497

    Accounts payable

    4,991

    5,025

    Advance from customers

    136,167

    Due to related parties

    728,869

    727,462

    Accrued payroll and employee benefits

    237,842

    165,986

    Other payables and accrued liabilities

    12,912,517

    5,665,558

    Income taxes payable

    417,906

    Total current liabilities

    21,418,934

    17,640,629

    Long-term loans

    4,503,932

    4,204,118

    Deferred gain on sale-leaseback

    52,314

    Lease liability – non-current

    483,866

    579,997

    Derivative liability

    54

    646,283

    Total liabilities (including amounts of the consolidated VIE without recourse
    to the Company of $20,084,995 and $16,784,878 as of December 31, 2023
    and 2022, respectively)

    26,406,786

    23,123,341

    Commitments and Contingencies

    Stockholders’ Equity

    Common stock, 50,000,000 shares authorized, $0.001 par value per share,
    10,065,920 shares issued and outstanding as of December 31, 2023 and
    2022.

    10,066

    10,066

    Additional paid-in capital

    89,172,771

    89,172,771

    Statutory earnings reserve

    6,080,574

    6,080,574

    Accumulated other comprehensive loss

    (10,555,534)

    (7,514,540)

    Retained earnings

    83,628,986

    93,575,021

    Total stockholders’ equity

    168,336,863

    181,323,892

    Total Liabilities and Stockholders’ Equity

    $

    194,743,649

    $

    204,447,233

     

     

     

    IT TECH PACKAGING, INC.

    CONSOLIDATED STATEMENTS OF INCOME (LOSS) AND COMPREHENSIVE INCOME (LOSS)

    FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

    Year Ended

    December 31,

    2023

    2022

    Revenues

    $

    86,546,950

    $

    100,352,434

    Cost of sales

    (85,547,065)

    (95,598,238)

    Gross Profit

    999,885

    4,754,196

    Selling, general and administrative expenses

    (9,075,475)

    (10,058,723)

    (Gain) Loss from disposal and impairment of property, plant
    and equipment

    (1,500,298)

    Loss from Operations

    (9,575,888)

    (5,304,527)

    Other Income (Expense):

    Interest income

    315,096

    24,264

    Interest expense

    (984,518)

    (1,027,951)

    Gain on acquisition

    30,994

    Gain (Loss) on derivative liability

    646,229

    1,417,251

    Loss before Income Taxes

    (9,599,081)

    (4,859,969)

    Provision for Income Taxes

    (346,954)

    (11,711,339)

    Net Loss

    (9,946,035)

    (16,571,308)

    Other Comprehensive Loss

    Foreign currency translation adjustment

    (3,040,994)

    (18,010,708)

    Total Comprehensive Loss

    $

    (12,987,029)

    $

    (34,582,016)

    Losses Per Share:

    Basic and Diluted Losses per Share

    $

    (0.99)

    $

    (1.66)

    Outstanding – Basic and Diluted

    10,065,920

    9,972,788

     

     

     

    IT TECH PACKAGING, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    FOR THE YEARS ENDED DECEMBER 31, 2023 AND 2022

    Year Ended

    December 31,

    2023

    2022

    Cash Flows from Operating Activities:

    Net income

    $

    (9,946,035)

    $

    (16,571,308)

    Adjustments to reconcile net income to net cash provided by operating
    activities:

    Depreciation and amortization

    14,225,990

    14,788,036

    (Gain) Loss on derivative liability

    (646,229)

    (1,417,251)

    (Gain) Loss from disposal and impairment of property, plant and equipment

    1,608,542

    (Recovery from) Allowance for bad debts

    34,193

    843,779

    Allowances for inventories, net

    2,970

    Share-based compensation and expenses

    156,000

    Gain on acquisition

    (30,992)

    Deferred tax

    10,261,104

    Changes in operating assets and liabilities:

    Accounts receivable

    280,970

    3,750,196

    Prepayments and other current assets

    9,322,532

    (3,976,010)

    Inventories

    (736,267)

    2,554,072

    Accounts payable

    50

    (4,496)

    Advance from customers

    136,686

    (37,452)

    Related parties

    (478,025)

    444,291

    Accrued payroll and employee benefits

    74,908

    (103,683)

    Other payables and accrued liabilities

    (596,695)

    677,840

    Income taxes payable

    (412,504)

    (614,738)

    Net Cash Provided by Operating Activities

    12,871,086

    10,719,388

    Cash Flows from Investing Activities:

    Purchases of property, plant and equipment

    (22,292,870)

    (4,534,092)

    Proceeds from sale of property, plant and equipment

    53,573

    Acquisition of land

    (6,364,439)

    Net Cash Used in Investing Activities

    (22,239,297)

    (10,898,531)

    Cash Flows from Financing Activities:

    Proceeds from issuance of shares and warrants, net

    Proceeds from short term bank loans

    1,275,546

    6,214,020

    Proceeds from long term loans

    3,769,948

    59,195

    Repayment of bank loans

    (7,647,610)

    (6,071,952)

    Payment of capital lease obligation

    (74,154)

    (206,114)

    Loan to a related party (net)

    7,086,369

    (874,745)

    Net Cash Provided by (Used in) Financing Activities

    4,410,099

    (879,596)

    Effect of Exchange Rate Changes on Cash and Cash Equivalents

    (174,835)

    (618,005)

    Net Decrease in Cash and Cash Equivalents

    (5,132,947)

    (1,676,744)

    Cash, Cash Equivalents and Restricted Cash – Beginning of Year

    9,524,868

    11,201,612

    Cash, Cash Equivalents and Restricted Cash – End of Year

    $

    4,391,921

    $

    9,524,868

    Supplemental Disclosure of Cash Flow Information:

    Cash paid for interest, net of capitalized interest cost

    $

    1,484,461

    $

    320,568

    Cash paid for income taxes

    $

    759,458

    $

    2,049,911

    Cash and bank balances

    3,918,938

    9,524,868

    Restricted cash

    472,983

    Total cash, cash equivalents and restricted cash shown in the statement of
    cash flows

    4,391,921

    9,524,868